larotrectinib Treatment for Solid Tumors Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers STAMFORD, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically […]Continue Reading ...
January 17, 2018 Obese, middle-age men and women who had bariatric surgery have half the death rate of those who had traditional medical treatment over a 10-year period, reports a study that answers questions about the long-term risk of the surgery. The study was by Northwestern University Feinberg School of Medicine and the Clalit Research […]Continue Reading ...
WASHINGTON — All gadolinium contrast agents used in magnetic resonance imaging (MRI) must now carry a warning about their retention in the body, which has been linked to adverse renal effects, the FDA said Tuesday. “The FDA reviewed available data about the retention of gadolinium from gadolinium-based contrast agents as part of its role in […]Continue Reading ...
By Dr Ananya Mandal, MD,January 15, 2018 Researchers have found that several genes within an ancient species of fish can be used to provide clues in the treatment of spinal cord damage. The study titled, “Highly Conserved Molecular Pathways, Including Wnt Signaling, Promote Functional Recovery from Spinal Cord Injury in Lampreys,” appeared in the latest […]Continue Reading ...
Patients receive care for the Spanish flu at Walter Reed Military Hospital, in Washington, D.C. Credit: origins.osu.edu This year marks the 100th anniversary of the great influenza pandemic of 1918. Between 50 and 100 million people are thought to have died, representing as much as 5 percent of the world’s population. Half a billion people […]Continue Reading ...
NORTH CHICAGO, Ill., Dec. 4, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced positive top-line results from IMMhance, the fourth pivotal Phase 3 clinical trial evaluating risankizumab (150 mg) for the treatment of patients with moderate to severe plaque psoriasis.1 There were two phases in this study. Results […]Continue Reading ...
Treatment for Dyspareunia TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR BOCA RATON, Fla.–(BUSINESS WIRE)–Dec. 19, 2017– TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women’s healthcare company, today announced the acceptance of the New Drug Application (NDA) resubmission for TX-004HR, the company’s investigational applicator-free estradiol vaginal softgel […]Continue Reading ...
January 16, 2018 Teens who were severely bullied as children by peers are at higher risk of mental health issues, including suicidal thoughts and behaviors, according to new research in CMAJ (Canadian Medical Association Journal). “Our findings showed a general tendency, in about 15% of the children, of being exposed to the most severe levels […]Continue Reading ...
By Dr Ananya Mandal, MD,January 16, 2018 According to the Public Health England (PHE) there are “large outbreaks” of measles in Europe that is cause for concern. Those travelling to Romania, Italy and Germany, says the PHE, without getting the measles vaccine (MMR) are at a greater risk of getting the infection. United Kingdom in […]Continue Reading ...
Lipoprotein(a) isn’t often tested for or well understood by most clinicians, but can have a big risk for premature heart disease in people who otherwise seem healthy. (New York Times) One lot of clopidogrel (Plavix) tablets from International Laboratories is being recalled after some bottles containing simvastatin were mislabeled as clopidogrel, which could be a […]Continue Reading ...
January 15, 2018 UCLA bioengineering professor Ali Khademhosseini has led the development of a tissue-based soft robot that mimics the biomechanics of a stingray. The new technology could lead to advances in bio-inspired robotics, regenerative medicine and medical diagnostics. The study was published in Advanced Materials. The simple body design of stingrays, specifically, a flattened […]Continue Reading ...
Credit: CC0 Public Domain The long-awaited results from the first large international trial to try to prevent type 1 diabetes shows that modified baby formula in which cow’s milk proteins have been split does not prevent type 1 diabetes in children with genetic risk factors for the condition, according to researchers at Children’s Hospital of […]Continue Reading ...
January 16, 2018 When diagnosing a heart attack, accuracy and timing are everything. A new test designed to better measure levels of troponin, a protein released when the heart muscle is damaged, could help emergency department physicians provide faster diagnosis and appropriate treatment. Known as high-sensitivity troponin (hsTn) assays, these blood tests became available for […]Continue Reading ...
January 16, 2018 ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers. According […]Continue Reading ...
(HealthDay)—The risk of mortality is increased for certain patients undergoing percutaneous coronary intervention (PCI) with incomplete revascularization (IR), according to a study published online Dec. 27 in JAMA Cardiology. Edward L. Hannan, Ph.D., from the University at Albany in New York, and colleagues examined the correlation between coronary vessel characteristics and outcomes in patients with […]Continue Reading ...
- Lactation May Lower T2D Risk in Younger Women
- New Atopic Dermatitis Yardstick provides practical guidance and management insights
- New biodegradable pressure sensor could help monitor serious health conditions
- HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
- Study identifies six new genes regions associated with diabetes
- Women do not receive timely diagnosis for heart disease
- AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
- Should President Trump’s Physical Include a Cognitive Screen?
- Could gene therapy someday eliminate HIV?
- Researchers identify new anti-inflammatory drug target
- Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
- Trunk Imaging Tied to Higher Nephrectomy Risk
- Campaigners incensed at failings in Africa AIDS war
- Research opens door to development of new treatment for type 2 diabetes
- Bariatric surgery extends lifespan in obese patients, shows study
- Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
- Ewww Moments in the ER: That’s Improbable!
- Methods from optogenetics, machine learning should help improve treatment options for stroke patients
- Booze may help or harm the heart, but income matters
- Three-dimensional organization of genome plays key role in gene expression, cell fate